Controlling Costs of Drug Discovery Through Automation

Written by: Peter Harris, CEO, HighRes Biosolutions The escalating cost of discovering new biopharmaceutical therapies is a well-known and long-standing problem. Recent estimates by the Tufts Center for the Study of Drug Development put the cost of developing and getting approval for a new drug just shy of $3 billion1. The underlying buildup of costs, […]

What’s the future of lab automation?

Lab automation has come a long way since the days of industrial robots, with new advancements increasing efficiency between systems and workers. Peter Harris, HighRes Biosolutions, discusses how far the sector has moved and what the future holds. The use of automation and robotics in scientific research has been around for quite some time, starting […]

Robotics Business Review

HighRes Biosolutions Accelerates Pharmaceutical Research With Automation

As an integrator, HighRes Biosolutions intimately knows its customers’ needs, as the biopharmaceuticals industry looks to save money and speed testing with robots.’ The pharmaceuticals industry is ideal for robotics, requiring precision, repeatability, and strict standards compliance. Scientists working on drug discovery, molecular diagnostics, and other research rely on integrators such as HighRes Biosolutions Inc. […]

Bloomberg Businessweek

These Modular Lab Systems Could Further Automate Drug Development

Modular automation from HighRes Biosolutions lets lab technicians quickly disconnect, move, and reconnect mobile carts containing robotic arms and other devices, expanding the range of experiments that can be performed at a single site. The Benefit One HighRes system can do the work of 20 to 30 lab techs with fewer errors, enabling faster development […]

Wall Street Journal

How Robots Are Making Better Drugs, Faster

Robotic lab techs don’t need to stop for rest. Unlike humans, they can shuttle samples 24/7. Featured on By Daniela Hernandez The scientist hunched over beakers, conducting drug research by hand, may soon be a memory. Companies like Eli Lilly & Co. and GlaxoSmithKline PLC are investing in automation with the hope of transforming […]

Robotics Business Review

Flexibility, Collaboration Key When Building Robots That May Cure Cancer

From Robotics Business Review For biopharmaceutical companies looking to discover the next big breakthrough in the fight against cancer, automating their processes can literally be a matter of life and death. With billions of dollars being spent to research drug discovery, finding ways to more quickly automate research is a high priority. HighRes Biosolutions aims […]


HighRes Biosolutions Modularizes Lab Automation and Favors Collaborative Robotics

Life Sciences Labs Need Cobots, Not Robots The John Henry legend, as told by Johnny Cash, not only recalls a competition between a steel-driving man and a steamdrill, it also suggests that the competition was poorly conceived: John Henry said to the steamdrill, “How is you? / Pardon me, Mister Steamdrill, I suppose you didn’t […]


Liquid Handling Gets Connected

Collaborative robots, ultrasonic acoustic energy, picodroplet technology, and cloud computing are among the technologies advancing liquid handling—simplifying workflows and raising efficiency and productivity levels. These new, often automated, and efficient solutions are frequently enabled by connections—between human operators and robots, among complementary technologies, or via the cloud. Working with robots Massachusetts-based HighRes Biosolutions develops robotic […]

Better Business Journal

HighRes featured in Boston Business Journal Article on Robotics Sector

Robotics sector thrives in Massachusetts as automation firms add to their ranks The “automation innovation” that defined last year’s list of the Largest Robotics Companies in Massachusetts continues to dominate, with nine new companies on our list and hundreds more employees. Click here to read full article Click here to download PDF